RETRACTED: Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Breast Cancer

This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy). This article has been retracted at the request of the Editor-in-Chief. Molecular Therapy is retracting this article. After a reader raised concerns about the article, the Editor-in-Chief found that Figure 1 was reused without attribution to the authors' previous work (Sun et al., 2018, Aging (Albany NY) 10, 973-987, https://dx.doi.org/10.18632/aging.101441) (although the pan-cancer analysis of E2F family using Oncomine database shared the same image to summarize the transcriptional levels of E2F family in different cancer types), and images were also duplicated in Figure 4. The author maintains that Figure 1 was not reused because it was generated using Oncomine.org, and the image duplications in Figure 4 were the result of unintentional errors that do not affect the interpretation of the results. The editors maintain that these issues have raised serious concerns about the validity of the results. This reuse (and in part, misrepresentation) of data without appropriate attribution represents a severe abuse of the scientific publishing system. Retraction Notice to: Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Breast CancerSun et al.Molecular TherapyMay 23, 2022In Brief(Molecular Therapy 27, 1153–1165, June 2019) Full-Text PDF